The company develops new front-end instrumentation for mass spectrometry.
Its main objectiveis to simplify methods and instrumentation by integrating novel technology with next generation mass spectrometer systems.
Biomotif has developed the proprietary pI Trap åcelus™ for advanced proteomics and biomarker studies. The technology is based on several new inventions including ElectroCapture.
Biomotif has granted patents (IPR; No. US 7,731,827 & US 8,237,117 ) on ElectroCapture technology.
Biomotif has also filed a PCT application for the more complex pI Fractionator technology.
Thorleif Lavold is a businessman and entrepreneur with focus on mass spectrometry and life science applications.
In addition to Biomotif AB (2005), he has started Zula Diagnostics AB (2012) and HDXperts AB (2014).
Thorleif has more than 25 years of experience in the sales, marketing and launching of new mass spectrometers, and a successful background in multiple instrumentation companies: VG Instruments Ltd., Fisons Plc, Micromass AB (CEO) and Waters AB (Business Development).
He was Sales and Managing Director in Micromass, where he sold the two first Q-Tof hybrid mass spectrometers in the world to Astra Zeneca and Pharmacia.
In 2005, Thorleif founded Biomotif, and two patents were purchased related to the ElectroCapture technology.
Biomotif holds patents in the field of ElectroCapture, H/D Exchange MS (licensed to HDXperts AB) and pI Trap technology.
In 2014 Thorleif started HDXperts, a CRO offering Fee for service for molecular interactions and Epitope Mapping.
Dr. J.A.Wells is a Pharmacist and holds a PhD in Medical Biochemistry.
He has extensive experience in instrument building and testing, with special knowledge of in the combination of capillary isoelectric focusing, capillary electrophoresis and membrane-based capillary electrophoresis with mass spectrometry for the analysis of proteins and peptides. Juan is co-author on 24 peer-reviewed publications related to protein analysis by mass spectrometry